Carregant...

A growing family: Adding mutated Erbb4 as a novel cancer target

As the upward spiral of novel cancer gene discoveries and novel molecular compounds continues to accelerate, a repetitive theme in molecular drug development remains the lack of activity of initially promising agents when given to patients in clinical trials. It is however invigorating that a few ta...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rudloff, Udo, Samuels, Yardena
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3384517/
https://ncbi.nlm.nih.gov/pubmed/20404484
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!